Rounsaville Bruce J
Yale University School of Medicine, VA CT Healthcare Systems, West Haven, CT 06516, USA.
Psychopathology. 2002 Mar-Jun;35(2-3):82-8. doi: 10.1159/000065124.
'Substance Use Disorders' represents a diagnostic subgroup in which ICD-10 and DSM-IV agree in most generalities and many particulars. Both systems' use disorders are based on the 'dependence syndrome' construct by Edwards and Gross and include a large and overlapping set of substance-induced syndromes. Differences at the category level are limited to DSM-IV 'abuse' vs. ICD-10 'harmful use', elimination of 'pathological alcohol intoxication' from DSM-IV and inclusion of substance-induced 'sexual dysfunctions and sleep disorders' in DSM-IV, but not in ICD-10. Cross-system reconciliation would entail few conceptual compromises but many criterion changes. Before embarking on a reconciliation process, the benefits of a common, world-wide nomenclature must be weighed against the many costs of changing either system. Even small changes can yield large differences in rates, reduce comparability across data gathered with different systems and incur considerable costs related to clinician retraining, changes in record keeping and changes in diagnostic interview schedules. Moreover, empirical data can have limited impact on the choices between the two systems because findings are either absent or equivocal, particularly for differences at the criterion level. Nevertheless, more research is needed particularly to examine the comparative reliability and validity of abuse and harmful use diagnoses.
“物质使用障碍”代表了一个诊断亚组,在这个亚组中,国际疾病分类第十版(ICD - 10)和《精神疾病诊断与统计手册》第四版(DSM - IV)在大多数一般性要点和许多具体细节上达成了一致。两个系统的使用障碍均基于爱德华兹(Edwards)和格罗斯(Gross)提出的“依赖综合征”概念,并且包含大量相互重叠的物质诱发综合征。类别层面的差异仅限于DSM - IV中的“滥用”与ICD - 10中的“有害使用”,DSM - IV删除了“病理性酒精中毒”,以及DSM - IV纳入了物质诱发的“性功能障碍和睡眠障碍”,而ICD - 10中未纳入。跨系统协调需要在概念上做出较少的妥协,但要进行许多标准更改。在着手进行协调过程之前,必须权衡通用的全球命名法的益处与更改任何一个系统所带来的诸多成本。即使是微小的更改也可能导致发生率出现巨大差异,降低使用不同系统收集的数据之间的可比性,并产生与临床医生再培训、记录保存更改以及诊断访谈时间表更改相关的可观成本。此外,实证数据对两个系统之间选择的影响可能有限,因为相关研究结果要么不存在,要么模棱两可,尤其是在标准层面的差异方面。然而,仍需要更多研究,特别是要检验滥用和有害使用诊断的相对可靠性和有效性。